Why major pharmaceutical and biotech companies will keep growing for years
GILD

Several big pharmaceutical groups are undervalued according to Morningstar: Roche ($RHHBY), Bristol ($BMY), Merck ($MRK) and Pfizer ($PFE). These stocks are expected to grow an average of 5% annually through 2024. The COVID-19 pandemic has so far not had a major negative impact on expected performance. An expected average growth till 2024 The major pharmaceutical…

Update About Moderna After Trump Tightens Targets For A COVID-19 Vaccine
MRNA

US biotech company Moderna ($MRNA) is talking with the Japanese health ministry about the supply of 40 million corona vaccines. The company confirmed this Friday afternoon after Japanese minister Kato Katsunobu communicated about this in national media. The vaccine will be supplied by Moderna, while Takeda Pharmaceutical will be responsible for distribution. The company would…

Keep An Eye On Ocugen: What Do The Insiders Know Since They Only Buy Shares
OCGN

Breakout Stocks   Corona Virus Stocks The purchases and sales of insiders of Ocugen, Inc. (NASDAQ: $OCGN) were reviewed today. Ocugen is a biopharmaceutical company focused on discovering, developing, and commercializing transformative therapies to cure blindness diseases. Their modifier gene therapy platform has the potential to treat multiple retinal diseases with one single drug. “Insiders can sell…